The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Chinese advanced fusion-dependent lung cancer patients: Molecular spectrum and treatment options using next generation sequencing—A multicenter study (Yangtze River Delta Lung Cancer Cooperation Group-001).
 
Wen Xian Wang
No Relationships to Disclose
 
Chun-Wei Xu
No Relationships to Disclose
 
Ziming Li
No Relationships to Disclose
 
Zhengbo Song
No Relationships to Disclose
 
Wenfeng Fang
No Relationships to Disclose
 
Liyun Miao
No Relationships to Disclose
 
You-Cai Zhu
No Relationships to Disclose
 
Shirong Zhang
No Relationships to Disclose
 
Bin-Bin Song
No Relationships to Disclose
 
Xue-Fei Shi
No Relationships to Disclose
 
Genhua Yu
No Relationships to Disclose
 
Huafei Chen
No Relationships to Disclose
 
Chuangzhou Rao
No Relationships to Disclose
 
Jianhui Huang
No Relationships to Disclose
 
Ping Zhan
No Relationships to Disclose
 
Hongbing Liu
No Relationships to Disclose
 
Qian Wang
No Relationships to Disclose
 
Tang-Feng Lv
No Relationships to Disclose
 
Yong Song
Consulting or Advisory Role - Hansoh Pharma
Research Funding - Hansoh Pharma (Inst)
 
Shun Lu
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; GenomiCare; Hutchison MediPharma; Menarini; Pfizer; PrIME Oncology; Roche; Simcere; Yuhan; Zai Lab
Speakers' Bureau - AstraZeneca; Hansoh; Hengrui Therapeutics; Roche
Research Funding - AstraZeneca; BMS; Hansoh; HenRui; Hutchison MediPharma; Roche